Glucemia y concentraciones de insulina en sangre de ratas Wistar sometidas a dieta alta en grasa y a tratamiento con péptidos miméticos de leptina
Palabras clave:
glucosa de la sangre, insulina, grasas en la dieta, péptidos, leptina, ratas Wistar
Resumen
Introducción. La administración de leptina ha demostrado que revierte la resistencia a la insulina y ejerce efectos sobre el metabolismo de la glucosa.Objetivo. Evaluar los cambios en las concentraciones plasmáticas de insulina y glucosa por la administración intraperitoneal de péptidos miméticos de leptina en ratas Wistar alimentadas con dieta alta en grasa.
Materiales y métodos. Se definió un grupo de ratas control alimentado con dieta alta en grasa y un grupo control con dieta normal; además, distintos grupos de animales alimentados con dieta alta en grasa y sometidos a la administración de siete diferentes péptidos de leptina, administrados en cuatro concentraciones diferentes y a los cuales se denominó grupos tratamiento. Durante la administración de los péptidos se cuantificó la glucemia y al finalizar las concentraciones de insulina.
Resultados. Las concentraciones de insulina en los grupos fueron similares; se observó hiperinsulinemia en los grupos a los cuales se les administró el péptido denominado 83 a dosis de 10 mg/kg y 20 mg/kg de peso corporal. Todos los tratamientos, a excepción del grupo al cual se le administró el péptido denominado con el código 80, redujeron la glucemia; el mayor efecto parece ser el del péptido 116-130 de leptina de ratón y su homólogo humano, aunque sin diferencias estadísticas con los otros tratamientos.
Conclusión. Los péptidos no ejercen efectos sobre las concentraciones de insulina pero sí sobre la glucemia; se requieren otras investigaciones para determinar los mecanismos mediante los cuales los péptidos intervienen en el metabolismo de la glucosa, sobre la expresión, secreción, mecanismos de señalización y regulación de la insulina, además, cambios en las concentraciones de insulina teniendo en cuenta el ritmo pulsátil de la hormona.
Descargas
Los datos de descargas todavía no están disponibles.
Referencias bibliográficas
1. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature. 1998; 395: 763-70.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-32.
3. Madej T, Boguski MS, Bryant SH. Threading analysis suggest that the obese gene product may be a helical cytokine. FEBS Lett. 1995; 373: 13-8.
4. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, et al. Crystal structure of the obese protein leptin-E100. Nature. 1997; 387: 206-9.
5. Cammisotto PG, Bukowiecki LJ. Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol. 2002; 283: C244-50.
6. Considine RV. Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. Semin Vasc Med. 2005; 5: 15-24.
7. Rayner DV, Trayhurn P. Regulation of leptin production: sympathetic nervous system interactions. J Mol Med. 2001; 79: 8-20.
8. Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun. 1997; 240: 590-4.
9. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998; 18: 559-72.
10. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001; 104: 531-43.
11. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology. 2002; 143: 239-46.
12. Jacob RJ, Dziura J, Medwixk MB, Leone P, Caprio S, During M, et al. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 1997; 46: 150-2.
13. Mercer JG, Hoggard N, Williams LM; Lawrence CB, Hannah LT, Trahurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain region by in situ hybridization. FEBS Lett. 1996; 387: 113-6.
14. Savioz A, Charnay Y, Huguenin C, Graviou C, Greggio B, Bouras C. Expression of leptin receptor mRNA (long form splice variant) in the human cerebellum. Neuroreport. 1997; 8: 3123-6.
15. Schwarts MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest. 1996; 98: 1101-6.
16. Grasso P, Leinung MC, Ingher SP, Lee DW. In vivo effects of leptin related synthetic peptides on body weight and food intake in female ob/ob mice. Localization of leptin activity to domains between aminoacid residues 106-140. Endocrinology. 1997; 138: 1413-8.
17. Rozhavskaya-Arena M, Lee DW, Leinung MC, Grasso P. Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation. Endocrinology. 2000; 141: 2501-7.
18. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord. 2000; 24: 639-46.
19. Vasselli JR. Behavioral and biological determinants of leptin resistance. Appetite. 2001; 37: 115-7.
20. Fernandez-Galaz C, Fernandez-Agullo T, Perez C, Peralta S, Arribas C, Andres A, et al. Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats. Diabetologia. 2002; 45: 997-1003.
21. Kim-Motoyama H, Yamaguchi T, Katakura T, Miura M, Ohashi Y, Yazaki Y, et al. Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity. Biochem Biophys Res Commun. 1997; 239: 340-4.
22. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes. 1996; 45: 695-8.
23. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol. 2003; 24: 225-53.
24. Steinberg GR, Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab. 2000; 279: E1374-82.
25. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L. Overfeeding rapidly induces leptin and insulin resistance. Diabetes. 2001; 50: 2786-91.
26. Yaspelkis B 3rd, Singh MK, Krisan AD, Collins DE, Kwong CC, Bernard JR, et al. Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci. 2004; 74: 1801-16.
27. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem. 1997; 272: 10585-93.
28. Walder K, Filipps A, Clark S, Zimmet P, Collier GR. Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol. 1997; 155: R5-7.
29. Zhao AZ, Bornfeldt KE, Beavo JA. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest. 1998; 102: 869-73.
30. Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A. High leptin levels acutely inhibit insulin-stimualted glucose uptake without affecting glucose transporter 4 traslocation in L6 rat skeletal muscle cells. Endocrinology. 2001; 142: 4806-12.
31. Pérez C, Fernández-Galaz C, Fernández-Agulló T, Arribas C, Andrés A, Ros M, et al. Leptin impairs insulin signaling in rat adipocytes. Diabetes. 2004; 53: 347-53.
32. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats. Endocrinology. 1997; 138: 3395-401.
33. Lichnovska R, Gwozdziewiczova S, Chlup R, Hrebicek J. Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005; 149: 119-26.
34. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996; 81: 4406-13.
35. Guven S, El-Bershawi A, Sonnenberg GE, Wilson CR, Hoffmann RG, Krakower GR, et al. Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: relationships with body composition and insulin. Diabetes. 1999; 48: 347-52.
36. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology. 1997; 138: 4463-72.
37. Doucet E, ST-Pierre S, Almeras N, Mauriege P, Despres J, Richard D, et al. Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study. J Clin Endocrinol. 2000; 85: 4231-6.
38. Vidal H, Auboeuf D, de Vos P, Staels B, Riou JP, Auwerx J, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest. 1996; 98: 251-5.
39. Wang J, Chinookoswong N, Scully S, Qi M, Shi ZQ. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology. 1999; 140: 2117-24.
40. Hidaka S, Yoshimatsu H, Kondou S, Tsuruta Y, Oka K, Noguchi H, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J. 2002; 16: 509-18.
41. Grasso P, Rozhavskaya- A, Leinung MC, Lee DW. D-Leu-4- OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6jJ ob/ob mice. Regul Pept. 2001; 101: 123-9.
42. Poveda E, Lareo L. Diseño teorico de péptidos miméticos de leptina diseñados por computador y postulados como farmacóforos potenciales para tratamiento de obesidad. Lecturas sobre Nutrición 2001; 3: 40-52.
43. Fong TM, Huang RR, Tota MR, Mao C, Smith T, Varnerin JVV, et al. Localization of leptin binding domain in the leptin receptor. Mol Pharmacol. 1998; 53: 234-40.
44. Sarin VK, Kent SB, Tam JP, Merrifield RB. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem. 1981; 117: 147-57.
45. Guzman F, Barberis S, Lllanes A. Peptide synthesis: chemical or enzymatic. Electronic Journal of Biotechnology. 2007; 10: 279-314. Consultado: mayo 7 de 2007. Disponible en: http://www.ejbiotechnology.info/content/vol10/issue2/full/13/13.pdf.
46. Santovena A, Oliva A, Guzman F, Patarroyo ME, Llabres M, Fariña JB. Chromatographic characterization of synthetic peptides: SPf66 malaria vaccine. J Chromatog B Analyt Technol Biomed Life Sci. 2002; 766: 3-12.
47. Noya O, Patarroyo ME, Guzmán F, Alarcón de Noya B. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci. 2003; 4: 299-308.
48. Khanam R, Pillai KK. Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic patways and potassium channels. Basic Clin Pharmacol Toxicol. 2006; 98: 155-9.
49. Cha MC, Jones PJ. Dietary fat type and energy restriction interactively influence plasma leptin concentration in rats. J Lipid Res. 1998; 39: 1655-60.
50. Steinberg GR, Dyck DJ. Development of leptin resistance in rat soleus Muscle in response to high-fat diets. Am J Physiol Endocrinol Metab. 2000; 279: E1374-82.
51. Lu H, Duanmu Z, Houck C, Jen KL, Buison A, Dunbar JC. Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res Bull. 1998; 47: 331-5.
52. Ainslie DA, Proietto J, Fam BC, Thorburn AW. Short-term, high-fat diets lower circulating leptin concentrations in rats. Am J Clin Nutr. 2000; 71: 438-42.
53. Eiden S, Preibisch G, Schmidt I. Leptin responsiveness of juvenile rats: proof of leptin function within the physiological range. J Physiol. 2001; 530: 131-9.
54. Tulipano G, Vergini AV, Soldi D, Muller EE, Cochi D. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant fed a high-fat diet. J Endocrinol. 2004; 183: 289-98.
55. Otukonyong EE, Dube MG, Torto R, Kalra PS, Kalra SP. High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obes Res. 2005; 13: 991-9.
56. Archer ZA, Rayner DV, Rozman J, Klingenspor M, Mercer JG. Normal distribution of body weight gain in male Sprague-Dawley rats fed a high-energy diet. Obes Res. 2003; 11: 1376-83.
57. Jang I, Hwang D, Lee J, Chae K, Kim Y, Kang T, et al. Physiological difference between dietary obesity-susceptible and obesity-resistant Sprague Dawley rats in response to moderate high fat diet. Exp Anim. 2003; 52: 99-107.
58. Otukonyong EE, Dube MG, Torto R, Kalra PS, Kalra SP. High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obes Res. 2005; 13: 991-9.
59. Huang BW, Chiang MT, Yao HT, Chiang W. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab. 2004; 6: 120-6.
60. Buetnner R, Newgard CB, Rhodes CJ, ODoherty RM. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab. 2000; 278: E563-9.
61. Oliveira VX Jr, Fazio MA, Miranda MT, da Silva JM, Bittencourt JC, Elias CF, et al. Leptin fragments induce Fos immunoreactivity in rat hypothalamus. Regul Pept. 2005; 127: 123-32.
62. Clegg DJ, Riedy CA, Smitk K, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003; 52: 682-7.
63. Matsuo T, Iwashita S, Komuro M, Suzuki M. Effects of high-fat diet intake on glucose uptake in central and peripheral tissues of non-obese rats. J Nutr Sci Vitaminol (Tokyo). 1999; 45: 667-73.
64. Langouche L, van den Berghe G. Glucose metabolism and insulin therapy. Crit Care Clin. 2006; 22: 119-29.
2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994; 372: 425-32.
3. Madej T, Boguski MS, Bryant SH. Threading analysis suggest that the obese gene product may be a helical cytokine. FEBS Lett. 1995; 373: 13-8.
4. Zhang F, Basinski MB, Beals JM, Briggs SL, Churgay LM, Clawson DK, et al. Crystal structure of the obese protein leptin-E100. Nature. 1997; 387: 206-9.
5. Cammisotto PG, Bukowiecki LJ. Mechanisms of leptin secretion from white adipocytes. Am J Physiol Cell Physiol. 2002; 283: C244-50.
6. Considine RV. Human leptin: an adipocyte hormone with weight-regulatory and endocrine functions. Semin Vasc Med. 2005; 5: 15-24.
7. Rayner DV, Trayhurn P. Regulation of leptin production: sympathetic nervous system interactions. J Mol Med. 2001; 79: 8-20.
8. Fruhbeck G, Aguado M, Martinez JA. In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun. 1997; 240: 590-4.
9. Hakansson ML, Brown H, Ghilardi N, Skoda RC, Meister B. Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus. J Neurosci. 1998; 18: 559-72.
10. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell. 2001; 104: 531-43.
11. Grill HJ, Schwartz MW, Kaplan JM, Foxhall JS, Breininger J, Baskin DG. Evidence that the caudal brainstem is a target for the inhibitory effect of leptin on food intake. Endocrinology. 2002; 143: 239-46.
12. Jacob RJ, Dziura J, Medwixk MB, Leone P, Caprio S, During M, et al. The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus. Diabetes 1997; 46: 150-2.
13. Mercer JG, Hoggard N, Williams LM; Lawrence CB, Hannah LT, Trahurn P. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain region by in situ hybridization. FEBS Lett. 1996; 387: 113-6.
14. Savioz A, Charnay Y, Huguenin C, Graviou C, Greggio B, Bouras C. Expression of leptin receptor mRNA (long form splice variant) in the human cerebellum. Neuroreport. 1997; 8: 3123-6.
15. Schwarts MW, Seeley RJ, Campfield LA, Burn P, Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Invest. 1996; 98: 1101-6.
16. Grasso P, Leinung MC, Ingher SP, Lee DW. In vivo effects of leptin related synthetic peptides on body weight and food intake in female ob/ob mice. Localization of leptin activity to domains between aminoacid residues 106-140. Endocrinology. 1997; 138: 1413-8.
17. Rozhavskaya-Arena M, Lee DW, Leinung MC, Grasso P. Design of a synthetic leptin agonist: effects on energy balance, glucose homeostasis, and thermoregulation. Endocrinology. 2000; 141: 2501-7.
18. Lin S, Thomas TC, Storlien LH, Huang XF. Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice. Int J Obes Relat Metab Disord. 2000; 24: 639-46.
19. Vasselli JR. Behavioral and biological determinants of leptin resistance. Appetite. 2001; 37: 115-7.
20. Fernandez-Galaz C, Fernandez-Agullo T, Perez C, Peralta S, Arribas C, Andres A, et al. Long-term food restriction prevents ageing-associated central leptin resistance in wistar rats. Diabetologia. 2002; 45: 997-1003.
21. Kim-Motoyama H, Yamaguchi T, Katakura T, Miura M, Ohashi Y, Yazaki Y, et al. Serum leptin levels are associated with hyperinsulinemia independent of body mass index but not with visceral obesity. Biochem Biophys Res Commun. 1997; 239: 340-4.
22. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes. 1996; 45: 695-8.
23. Sahu A. Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol. 2003; 24: 225-53.
24. Steinberg GR, Dyck DJ. Development of leptin resistance in rat soleus muscle in response to high-fat diets. Am J Physiol Endocrinol Metab. 2000; 279: E1374-82.
25. Wang J, Obici S, Morgan K, Barzilai N, Feng Z, Rossetti L. Overfeeding rapidly induces leptin and insulin resistance. Diabetes. 2001; 50: 2786-91.
26. Yaspelkis B 3rd, Singh MK, Krisan AD, Collins DE, Kwong CC, Bernard JR, et al. Chronic leptin treatment enhances insulin-stimulated glucose disposal in skeletal muscle of high-fat fed rodents. Life Sci. 2004; 74: 1801-16.
27. Muller G, Ertl J, Gerl M, Preibisch G. Leptin impairs metabolic actions of insulin in isolated rat adipocytes. J Biol Chem. 1997; 272: 10585-93.
28. Walder K, Filipps A, Clark S, Zimmet P, Collier GR. Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol. 1997; 155: R5-7.
29. Zhao AZ, Bornfeldt KE, Beavo JA. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B. J Clin Invest. 1998; 102: 869-73.
30. Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A. High leptin levels acutely inhibit insulin-stimualted glucose uptake without affecting glucose transporter 4 traslocation in L6 rat skeletal muscle cells. Endocrinology. 2001; 142: 4806-12.
31. Pérez C, Fernández-Galaz C, Fernández-Agulló T, Arribas C, Andrés A, Ros M, et al. Leptin impairs insulin signaling in rat adipocytes. Diabetes. 2004; 53: 347-53.
32. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats. Endocrinology. 1997; 138: 3395-401.
33. Lichnovska R, Gwozdziewiczova S, Chlup R, Hrebicek J. Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005; 149: 119-26.
34. Havel PJ, Kasim-Karakas S, Mueller W, Johnson PR, Gingerich RL, Stern JS. Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss. J Clin Endocrinol Metab. 1996; 81: 4406-13.
35. Guven S, El-Bershawi A, Sonnenberg GE, Wilson CR, Hoffmann RG, Krakower GR, et al. Plasma leptin and insulin levels in weight-reduced obese women with normal body mass index: relationships with body composition and insulin. Diabetes. 1999; 48: 347-52.
36. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW. Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology. 1997; 138: 4463-72.
37. Doucet E, ST-Pierre S, Almeras N, Mauriege P, Despres J, Richard D, et al. Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: evidence from both a cross-sectional and an intervention study. J Clin Endocrinol. 2000; 85: 4231-6.
38. Vidal H, Auboeuf D, de Vos P, Staels B, Riou JP, Auwerx J, et al. The expression of ob gene is not acutely regulated by insulin and fasting in human abdominal subcutaneous adipose tissue. J Clin Invest. 1996; 98: 251-5.
39. Wang J, Chinookoswong N, Scully S, Qi M, Shi ZQ. Differential effects of leptin in regulation of tissue glucose utilization in vivo. Endocrinology. 1999; 140: 2117-24.
40. Hidaka S, Yoshimatsu H, Kondou S, Tsuruta Y, Oka K, Noguchi H, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J. 2002; 16: 509-18.
41. Grasso P, Rozhavskaya- A, Leinung MC, Lee DW. D-Leu-4- OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6jJ ob/ob mice. Regul Pept. 2001; 101: 123-9.
42. Poveda E, Lareo L. Diseño teorico de péptidos miméticos de leptina diseñados por computador y postulados como farmacóforos potenciales para tratamiento de obesidad. Lecturas sobre Nutrición 2001; 3: 40-52.
43. Fong TM, Huang RR, Tota MR, Mao C, Smith T, Varnerin JVV, et al. Localization of leptin binding domain in the leptin receptor. Mol Pharmacol. 1998; 53: 234-40.
44. Sarin VK, Kent SB, Tam JP, Merrifield RB. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem. 1981; 117: 147-57.
45. Guzman F, Barberis S, Lllanes A. Peptide synthesis: chemical or enzymatic. Electronic Journal of Biotechnology. 2007; 10: 279-314. Consultado: mayo 7 de 2007. Disponible en: http://www.ejbiotechnology.info/content/vol10/issue2/full/13/13.pdf.
46. Santovena A, Oliva A, Guzman F, Patarroyo ME, Llabres M, Fariña JB. Chromatographic characterization of synthetic peptides: SPf66 malaria vaccine. J Chromatog B Analyt Technol Biomed Life Sci. 2002; 766: 3-12.
47. Noya O, Patarroyo ME, Guzmán F, Alarcón de Noya B. Immunodiagnosis of parasitic diseases with synthetic peptides. Curr Protein Pept Sci. 2003; 4: 299-308.
48. Khanam R, Pillai KK. Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic patways and potassium channels. Basic Clin Pharmacol Toxicol. 2006; 98: 155-9.
49. Cha MC, Jones PJ. Dietary fat type and energy restriction interactively influence plasma leptin concentration in rats. J Lipid Res. 1998; 39: 1655-60.
50. Steinberg GR, Dyck DJ. Development of leptin resistance in rat soleus Muscle in response to high-fat diets. Am J Physiol Endocrinol Metab. 2000; 279: E1374-82.
51. Lu H, Duanmu Z, Houck C, Jen KL, Buison A, Dunbar JC. Obesity due to high fat diet decreases the sympathetic nervous and cardiovascular responses to intracerebroventricular leptin in rats. Brain Res Bull. 1998; 47: 331-5.
52. Ainslie DA, Proietto J, Fam BC, Thorburn AW. Short-term, high-fat diets lower circulating leptin concentrations in rats. Am J Clin Nutr. 2000; 71: 438-42.
53. Eiden S, Preibisch G, Schmidt I. Leptin responsiveness of juvenile rats: proof of leptin function within the physiological range. J Physiol. 2001; 530: 131-9.
54. Tulipano G, Vergini AV, Soldi D, Muller EE, Cochi D. Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant fed a high-fat diet. J Endocrinol. 2004; 183: 289-98.
55. Otukonyong EE, Dube MG, Torto R, Kalra PS, Kalra SP. High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obes Res. 2005; 13: 991-9.
56. Archer ZA, Rayner DV, Rozman J, Klingenspor M, Mercer JG. Normal distribution of body weight gain in male Sprague-Dawley rats fed a high-energy diet. Obes Res. 2003; 11: 1376-83.
57. Jang I, Hwang D, Lee J, Chae K, Kim Y, Kang T, et al. Physiological difference between dietary obesity-susceptible and obesity-resistant Sprague Dawley rats in response to moderate high fat diet. Exp Anim. 2003; 52: 99-107.
58. Otukonyong EE, Dube MG, Torto R, Kalra PS, Kalra SP. High-fat diet-induced ultradian leptin and insulin hypersecretion are absent in obesity-resistant rats. Obes Res. 2005; 13: 991-9.
59. Huang BW, Chiang MT, Yao HT, Chiang W. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab. 2004; 6: 120-6.
60. Buetnner R, Newgard CB, Rhodes CJ, ODoherty RM. Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab. 2000; 278: E563-9.
61. Oliveira VX Jr, Fazio MA, Miranda MT, da Silva JM, Bittencourt JC, Elias CF, et al. Leptin fragments induce Fos immunoreactivity in rat hypothalamus. Regul Pept. 2005; 127: 123-32.
62. Clegg DJ, Riedy CA, Smitk K, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003; 52: 682-7.
63. Matsuo T, Iwashita S, Komuro M, Suzuki M. Effects of high-fat diet intake on glucose uptake in central and peripheral tissues of non-obese rats. J Nutr Sci Vitaminol (Tokyo). 1999; 45: 667-73.
64. Langouche L, van den Berghe G. Glucose metabolism and insulin therapy. Crit Care Clin. 2006; 22: 119-29.
Cómo citar
1.
Poveda E, Trujillo P, Ruiz F, Lopez E. Glucemia y concentraciones de insulina en sangre de ratas Wistar sometidas a dieta alta en grasa y a tratamiento con péptidos miméticos de leptina. biomedica [Internet]. 1 de marzo de 2008 [citado 16 de abril de 2024];28(1):50-63. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/108
Algunos artículos similares:
- Juan Vergara, Silvia Hurtado, Víctor H. Alvarez, Myriam Arévalo, Sócrates Herrera, Caracterización de la transmisión de Plasmodium malariae en cuatro regiones colombianas endémicas de malaria , Biomédica: Vol. 21 Núm. 1 (2001)
- Silvana Marisa Montenegro, María Cristina Tarrés, Juan Carlos Picena, Stella Maris Martínez, Conducta alimentaria y perfil glucémico en dos líneas de ratas con diabetes genética: eSS y eSMT. , Biomédica: Vol. 25 Núm. 4 (2005)
- Martín Dadé, Martín Daniele, Nora Mestorino, Evaluación del efecto tóxico de la doramectina, la ivermectina y la eprinomectina sobre Triatoma infestans en un modelo de rata , Biomédica: Vol. 37 Núm. 3 (2017)
- Islendy Noreña, Myriam Patricia Pardo, Ismena Mockus, Niveles séricos de adipocitocinas y resistencia a la insulina en el primer trimestre de gestación en adolescentes y su relación con el peso del recién nacido , Biomédica: Vol. 38 Núm. 3 (2018)
- Raúl Isaías-Tizapa, Erika Acosta, Arvey Tacuba-Saavedra, Miguel Mendoza-Catalán, Napoleón Navarro-Tito, La leptina promueve la expresión de Hic-5 y la formación de puntos de actina por la vía dependiente de FAK-Src en células epiteliales mamarias MCF10A. , Biomédica: Vol. 39 Núm. 3 (2019)
- Jairo Tobar, Daniel Ramos Sarmiento, Diana Tayupanta, Melina Rodríguez, Fabián Aguilar, Evaluación microscópica y molecular de Strongyloides venezuelensis en un ciclo de vida experimental utilizando ratas Wistar , Biomédica: Vol. 41 Núm. Supl. 1 (2021): Mayo, Parasitología médica
- Idialis Hernández , Milenen Hernández, Jeny González, Ivonne Gómez, Orlando Zulueta, Grisell Ramos, Darien Ortega, Dunia Clara Bequer, Giosvany Ernesto Martínez, Aurora Delahanty, Evaluación del UMELISA CHAGAS® con la incorporación de nuevos péptidos monoméricos y quiméricos representativos de diferentes regiones de Trypanosoma cruzi , Biomédica: Vol. 41 Núm. Supl. 1 (2021): Mayo, Parasitología médica
Publicado
2008-03-01
Número
Sección
Artículos originales
| Estadísticas de artículo | |
|---|---|
| Vistas de resúmenes | |
| Vistas de PDF | |
| Descargas de PDF | |
| Vistas de HTML | |
| Otras vistas | |
